CX Institutional’s Inspire Medical Systems INSP Stock Holding History

CX Institutional’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-221	Closed	-$11K	–	1612
2026 Q1	$11K	Buy	+221	New	+$15.5K	﹤0.01%	1275

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CX Institutional's INSP Position: Q2 2026 in Review

CX Institutional sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 221 shares — an estimated $11K sold.

CX Institutional first reported a position in INSP in Q1 2026 and held it in 1 quarter. The position peaked at $11K in Q1 2026. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

CX Institutional reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
CX Institutional sold 221 Inspire Medical Systems shares in Q2 2026, an estimated $11K.
CX Institutional first reported a position in Inspire Medical Systems in Q1 2026 and held it in 1 quarter.
CX Institutional's Inspire Medical Systems position peaked at $11K in Q1 2026.
276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.